Trump launches tirade against NIAID chief Fauci as COVID-19 crisis escalatesThe war of words between Donald Trump and his top infectious diseases expert Dr Anthony Fauci has intensified Share XTrump launches tirade against NIAID chief Fauci as COVID-19 crisis escalateshttps://pharmaphorum.com/news/trump-launches-tirade-against-niaid-chief-fauci-as-covid-19-crisis-escalates/
UK government signs contract for COVID-19 challenge trialThe UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will Share XUK government signs contract for COVID-19 challenge trialhttps://pharmaphorum.com/news/uk-government-signs-contract-for-covid-19-challenge-trial/
Pfizer to wait until after election to file COVID-19 vaccine in USPfizer said it will wait until after the US election to file its COVID-19 vaccine with the US Share XPfizer to wait until after election to file COVID-19 vaccine in UShttps://pharmaphorum.com/news/pfizer-to-wait-until-after-election-to-file-covid-19-vaccine-in-us/
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trialGilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in Share XGilead’s COVID-19 drug Veklury falls short in WHO’s global trialhttps://pharmaphorum.com/news/gileads-covid-19-drug-veklury-falls-short-in-whos-global-trial/
Sanofi preps trials of second COVID-19 shot, as Russia approves anotherSanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after Share XSanofi preps trials of second COVID-19 shot, as Russia approves anotherhttps://pharmaphorum.com/news/sanofi-preps-trials-of-second-covid-19-shot-as-russia-approves-another/
Coronavirus re-infection case confirmed in the USThere is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of Share XCoronavirus re-infection case confirmed in the UShttps://pharmaphorum.com/news/coronavirus-re-infection-case-confirmed-in-the-us/
Lilly pauses COVID-19 antibody trial after factory hits trouble with FDAEli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found Share XLilly pauses COVID-19 antibody trial after factory hits trouble with FDAhttps://pharmaphorum.com/news/lilly-pauses-covid-19-antibody-trial-after-factory-hits-trouble-with-fda/
J&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’Johnson & Johnson has paused further dosing in its COVID-19 vaccine clinical trial following an “unexplained illness” in Share XJ&J’s late-stage COVID-19 vaccine trial halted after ‘unexplained illness’https://pharmaphorum.com/news/jjs-late-stage-covid-19-vaccine-trial-halted-after-unexplained-illness/
Chord gets $16m to challenge Alexion with oral NMOSD drugSwiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will Share XChord gets $16m to challenge Alexion with oral NMOSD drughttps://pharmaphorum.com/news/chord-gets-16m-to-challenge-alexion-with-oral-nmosd-drug/
